Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata
Al-Azhar International Medical Journal · 31.03.2025 · 2025 (3) · 122-128
DOI: 10.21608/aimj.2025.446474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 31.03.2025. Verfasst von Ahmed Mohammad Abdel Aal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aal, A. M. A., Abdelaty, A. S., & Muhammad, A. A. (2025). Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata. Al-Azhar International Medical Journal, 2025(3), 122-128. https://doi.org/10.21608/aimj.2025.446474
Vancouver
Aal AMA, Abdelaty AS, Muhammad AA. Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata. Al-Azhar International Medical Journal. 2025;2025(3):122-128. doi:10.21608/aimj.2025.446474
BibTeX
@article{Aal2025,
author = {Aal, Ahmed Mohammad Abdel and Abdelaty, Ahmed Shawky and Muhammad, Alshaimaa Abdullah},
title = {Intralesional Methotrexate versus Intralesional Triamcinolone acetonide in Treatment of Resistant Localized Alopecia Areata},
journal = {Al-Azhar International Medical Journal},
year = {2025},
volume = {2025},
number = {3},
pages = {122--128},
doi = {10.21608/aimj.2025.446474}
}
EUVIMED